Agenus Inc Stock In The News

AGEN Stock  USD 3.34  0.48  16.78%   
Our overall analysis of Agenus' news coverage and content from conventional and social sources shows investors' bearish mood towards Agenus Inc. The specific impact of Agenus news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Agenus' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Agenus headlines in addition to utilizing other, more conventional financial analysis modules. Check out Agenus Backtesting and Agenus Hype Analysis.

Agenus Today Top News and Investor Outlook

Yahoo News
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
https://finance.yahoo.com/news/gsks-respiratory-syncytial-virus-vaccine-140151377.html
 Neutral
Yahoo News
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
https://finance.yahoo.com/news/gsk-announces-positive-topline-data-110000099.html
 Neutral
Yahoo News
Ligand Reports Second Quarter 2024 Financial Results
https://finance.yahoo.com/news/ligand-reports-second-quarter-2024-200100583.html
 Bullish
Yahoo News
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
https://finance.yahoo.com/news/bristol-myers-squibb-terminates-cancer-183111963.html
 Neutral
Yahoo News
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
https://finance.yahoo.com/news/medical-moonshots-3-biotech-stocks-193029695.html
 Bullish
Yahoo News
7 Biotech Stocks to Put on Your Breakthrough Radar
https://finance.yahoo.com/news/7-biotech-stocks-put-breakthrough-163215430.html
 Neutral
Yahoo News
Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
https://finance.yahoo.com/news/agenus-inc-agen-q1-2024-070942372.html
 Bullish
Yahoo News
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
https://finance.yahoo.com/news/ligand-agenus-enter-100-million-113000923.html
 Bullish
Yahoo News
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
https://finance.yahoo.com/news/why-agenus-stock-plummeted-nearly-233805990.html
 Neutral
Yahoo News
Botensilimab/Balstilimab Breakthrough Da...
https://finance.yahoo.com/news/botensilimab-balstilimab-breakthrough-data-presented-123000097.html
 Neutral

Agenus Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Agenus and other traded companies coverage with news coverage. We help investors stay connected with Agenus headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Agenus Stock performance. Please note that trading solely based on the Agenus Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Agenus' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Agenus Inc investors visualize upcoming and past events in order to time the market based on Agenus Inc noise-free hype analysis.
Agenus stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Agenus earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Agenus that are available to investors today. That information is available publicly through Agenus media outlets and privately through word of mouth or via Agenus internal channels. However, regardless of the origin, that massive amount of Agenus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Agenus news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Agenus relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Agenus' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Agenus alpha.

Agenus Largest EPS Surprises

Earnings surprises can significantly impact Agenus' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2014-10-31
2014-09-30-0.15-0.130.0213 
2023-11-07
2023-09-30-0.19-0.160.0315 
2021-05-06
2021-03-31-0.31-0.270.0412 
2018-11-06
2018-09-30-0.25-0.29-0.0416 
2014-07-24
2014-06-30-0.16-0.120.0425 
2012-08-02
2012-06-30-0.27-0.31-0.0414 
View All Earnings Estimates

Agenus Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Agenus Inc Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
20th of November 2024
Agenus Inc. Receives 10.00 Consensus Target Price from Analysts - MarketBeat
at news.google.com 
Yahoo News
18th of November 2024
Agenus Loses -41.13 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corne...
at finance.yahoo.com 
zacks News
15th of November 2024
Down -39. percent in 4 Weeks, Heres Why Agenus Looks Ripe for a Turnaround
at zacks.com 
Gurufocus Stories at Macroaxis
14th of November 2024
Acquisition by Oday Steven J of 50000 shares of Agenus at 2.77 subject to Rule 16b-3
at gurufocus.com 
insidermonkey News
13th of November 2024
Agenus Inc. Q3 2024 Earnings Call Transcript
at insidermonkey.com 
businesswire News
12th of November 2024
Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOTBAL D...
at businesswire.com 
Gurufocus Stories at Macroaxis
11th of November 2024
Earnings To Watch Agenus Inc Reports Q3 2024 Result
at gurufocus.com 
Yahoo News
7th of November 2024
Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024
at finance.yahoo.com 
news
28th of October 2024
Shareholders That Lost Money on Agenus Inc. Should Contact Levi Korsinsky About Pending Cl...
at accesswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Agenus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Agenus' short interest history, or implied volatility extrapolated from Agenus options trading.
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out Agenus Backtesting and Agenus Hype Analysis.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.02)
Revenue Per Share
7.808
Quarterly Revenue Growth
0.033
Return On Assets
(0.22)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.